Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-17
Closed -$514 641
2025
Q4
$514 Buy
+17
New +$417 ﹤0.01% 387
2025
Q1
Sell
-15
Closed -$419 378
2024
Q4
$419 Sell
15
-13
-46% -$348 ﹤0.01% 465
2024
Q3
$571 Buy
+28
New +$627 ﹤0.01% 343
2024
Q2
Sell
-113
Closed -$3.45K 218
2024
Q1
$3.45K Buy
+113
New +$3.19K ﹤0.01% 171
2023
Q3
Sell
-135
Closed -$4.77K 435
2023
Q2
$4.77K Buy
+135
New +$3.78K ﹤0.01% 377
2022
Q3
Sell
-288
Closed -$7K 580
2022
Q2
$7K Sell
288
-104
-27% -$2.8K ﹤0.01% 266
2022
Q1
$16K Buy
+392
New +$20.4K ﹤0.01% 137

Other funds holding CFLT

Elequin Capital's CFLT Position: Q1 2026 in Review

Elequin Capital sold out of Confluent (CFLT) in Q1 2026, closing a stake of 17 shares — an estimated $514 sold.

Elequin Capital first reported a position in CFLT in Q1 2022 and held it in 7 quarters. The position peaked at $16K in Q1 2022. 4 funds tracked by Wall St. Rank hold CFLT as of Q1 2026.

  • Elequin Capital reported no remaining Confluent position as of Q1 2026 after selling out during the quarter.
  • Elequin Capital sold 17 Confluent shares in Q1 2026, an estimated $514.
  • Elequin Capital first reported a position in Confluent in Q1 2022 and held it in 7 quarters.
  • Elequin Capital's Confluent position peaked at $16K in Q1 2022.
  • 4 funds tracked by Wall St. Rank held Confluent as of Q1 2026.

Based on Elequin Capital's 13F filing for Q1 2026, filed 11 May 2026.